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Coronavirus covid-2019: Is this really an invisible
enemy or a warning to humanity?
Modeste Kameni Nematchoua1,2
Abstract: With more than 8 million confirmed cases, and more than four hundred and thirty thousand
deaths declared to date worldwide, the Coronavirus pandemic (COVID-19) is recognized as one of the deadliest
pandemics that the humanity has known in recent years. So far, although this disease has been declared as an
invisible enemy by many scientists and politicians, its origin remains without explanation more reliable and
reassuring by the scientific community. As a result, the following questions remain without explanation. Can this
pandemic be considered a warning to humanity? When will the end of this pandemic come? Has it become a
matter of industrial lobbies as said some people? The main purpose of this research is to analyse some research
related to the recently published Coronavirus (COVID-19) pandemic in order to offer some answers to these
questions. It emerges from this analysis that the most reliable solution to overcome this pandemic is to disclose
the results of the progress of this pandemic by the scientific, and to multiply public awareness campaigns.
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1 Background
Human beings believe dominate the world through their
knowledge. However, for centuries the origin of certain
pandemics and natural disasters has remained without
reliable explanation by the scientific community. Dur-
ing these decades, disasters have become more serious
worldwide. Indeed, earthquakes, plagues, famines, floods,
droughts, and insect invasions occur frequently and spread
all over the world. The following Table 1, shows some
natural disasters recorded since 11th century.
2 COVID-19 recognized as the novel pan-
demic
2.1 Origin
The new SARS-Cov2 coronavirus that causes Covid-
19 disease was first discovered in China, in the city of
Wuhan. Coronaviruses are a family of viruses that mainly
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Figure 1. Imagen of Coronavirus
affect animals. Some infect humans and most often cause
colds and mild influenza-like illness.
Some scientists say (that) may be coronaviruses come
from bats. Indeed, the bat is probably the animal reservoir
of this virus.
In contrast, some scientists believe that it is a virus that
escaped from one of the Chinese laboratories located in
Wuhan. The political quarrels, rivalry, competition, and
pride of certain governments prevent until now scientists
from determining the true cause of this disease.
2.2 History
The very first case reported from COVID 19, was a
55-year-old patient, who fell ill on November 17, 2019 in
China[2]. A month later, on December 15, the number of
cases reported was 27. On December 20, it increased to
60, including several people who worked at the Huanan
seafood market[3]. On December 21, the doctors real-
ized that they were in the presence of a new respiratory
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Table 1. Some disasters
Type Number of deaths Event Location Time (period)
Epidemics 250000000 Black Plague world 11th to 17th century
Epidemics 300 000 000 Smallpox world From 1900 to 1977[1]
Famines 29 000 000 Great famine in China China 1958–1961
Flood 2 072 500 Floods China 1931
Earthquake 830 000 Shaanxi earthquake China January 23, 1556
cyclones 362 000 Bhola cyclone Bangladesh November, 1970
Tsunami 225 500 Indian Ocean earthquake and tsunami Indonesia, Sri Lanka, India and Thailand December, 2004
Volcanic eruption 78 209 Krakatoa eruption Krakatoa, Indonesia August 27, 1883
Drought 70 000 European heat wave Europe 2003
Avalanche 20 000 The avalanche of Mount Huascarán Peru 1970
Hurricane 15 100 Vargas tragedy Venezuela 1999
Lightning 4 000 Palace of the Grand Master Explosion, Rhodes Greece 1856
Blizzard 4 000 Blizzard from 1972 in Iran Iran 1972
Fire 1 850 Peshtigo Fire Wisconsin, United States October 8, 1871
Limnic rash 1 744 Nyos Lake Cameroon 1986
Tornado 1 300 Daulatpur – Saturia Tornado Manikganj, Bangladesh 1989
Earthquake 22000 earth quake of magnitude 7 Haiti January 12, 2010
Earthquake 723 earth quake of magnitude 8.8 Chile February 27, 2010
Drought - Important drought 5 provinces in China March, 2010
Mud flow 1239 Huge mudslide Zhouqu in China August 07,2010
Flood 12 flood Australia January 12,2011
Earthquake 18500 tsunami Japan Mars 11,2011
Drought - Heat wave Germany and Swiss April, 2011
Volcanic eruption - Volcanic eruption Chile June 4, 2011
Flood 427 flood Thailand July-October, 2011
Famines More than 10000 Huge drought East- Africa July-August, 2011
Drought - drought record United States 2012
Flood 37 torrential rain Pekin-China July,2012
Hurricane 210 Hurricane Sandy United States October, 2012
Plague - Grasshopper invasion Israel March, 2013
Plague - H7L9 Avian Flu China March, 2013
Flood 5000 flood India June, 2013
Wind 1 Huge wind California-United States August 25, 2013
Blizzard 2 Blizzard Middle east December, 2013
Avalanche - Avalanche North of America January 2, 2014
Earthquake 9000 Earthquake of magnitude 7.8 Nepal April, 2015
Flood 12 flood Georgia June, 2015
Earthquake 676 Earthquake of magnitude 6.8 India January, 2016
Earthquake 700 earthquake Equator April, 2016
Earthquake 369 Earthquake Mexico September, 2017
Flood 100 torrential rain Japan July, 2018
Tsunami 2000 Earthquake and tsunami Indonesia September 28,2018
Pandemic More than 500000 Coronavirus world From December, 2019
Notes: This table shows some events, which affected the world before COVID19. Nowadays, the entire world is confronted to this pandemic.
pathogen. On December 31, 2019, a third country offi-
cially informed the world Health Organization (WHO)
of the occurrence of numerous cases of pneumonia of
unknown origin in the city of Wuhan. On January 6, the
United States Centres for Disease Control and Prevention
(US CDC) communicated about the risks of an epidemic.
On January 7, 2020, the Chinese authorities confirmed
that it was indeed a new virus from the coronavirus family,
temporarily baptized ”2019-nCoV”, and reported around
sixty victims. Wuhan coronavirus, known internation-
ally as ”2019 novel Coronavirus” abbreviated 2019-nCov,
sometimes called ”Wuhan seafood market pneumonia
virus”, is the coronavirus that causes the pneumonia epi-
demic from Wuhan, provisional name which was taken
up by the Institute Pasteur, because it is up to the World
Health Organization (WHO) to give its final name to this
new pathology. On January 9, 2020, the WHO launched
an international alert. On January 21, WHO released its
first daily report on the epidemic . On January 23, WHO
announced that the disease is communicable between hu-
mans . On January 24, the WHO indicated that the modes
of transmission of the disease are probably the same as
for other coronaviruses: direct contact via the respiratory
droplets ejected during speech (postillons), cough and
sneezing or via objects contaminated by these droplets.
On January 26, the National Health Commission of China
announced that the new virus has an incubation period
of up to two weeks, and most importantly, contagion is
possible during the incubation period. Therefore, if it is
not subject to a systematic and early detection policy, it is
likely to spread with exponential growth. On January 30,
WHO declared the epidemic a public health emergency of
international concern (USPPI). Some people mentioned
“disease X”, the name given in 2018 by the WHO to a
disease likely to cause international danger. On Febru-
ary 11, WHO officially named the disease: “Coronavirus
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disease 2019 (COVID-19). The virus was also named:
”severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2)”. On February 27, WHO published a guide on
preventive measures to curb the epidemic. On March 11,
the Director General of WHO described COVID-19 as
a pandemic, noting that it was the first time that a pan-
demic had been caused by a coronavirus. The pangolin
as shown in Figure 2, is one of the animals suspected of
having transmitted the virus to humans, via a market in
Wuhan.
Figure 2. An animal suspected of having transmitted the virus
to humans
2.3 Transmission
According to world Health Organization (WHO)[4],
COVID-19 is spread when people are in close contact via
small droplets emitted during conversation, sneezing, or
coughing. According to Disease Control and Prevention
(CDC)[5], contaminated droplets spread by infected peo-
ple are then inhaled into the lungs or deposited on the
face of others to cause a new infection. These very heavy
droplets, usually fall on surfaces without being spread far
in the air(Figure 3). Thus, transmission of the virus can
be done with no physical symptoms. The frequency with
which this occurs is not very clear. An estimation of the
number of asymptomatic infected people is around 40%.
Figure 3. Coronavirus spread in space by a patient
The vulnerability and transmission rate is very high
for people with mild or non-specific symptoms. The first
symptoms of the disease appear after two days or more,
these depend on the ability of the patient’s body to cope
with this disease. All patients are strongly affected by this
disease for seven to twelve days in moderate cases, and
on average two weeks in more severe cases[4].
When contaminated droplets emitted into space by con-
taminated people fall on soils, this surface remains in-
fected. If suddenly, healthy people touch these affected
surfaces, then their eyes, nose, or mouth with unwashed
hands[5]. They immediately get this disease. In contami-
nated surfaces, the amount of active virus decreases over
time until it can no longer cause an infection. Studies
have shown that saliva and sputum carry large amounts of
the virus[3–5]. Although this disease is not recognized as a
sexually transmitted disease, the fact remains that kissing,
intimate contact and the faecal-oral tract are suspected of
transmitting the virus[6].
It is not known how much virus on surfaces is needed
to cause infection via this method, but it can be detected
for up to four hours on copper, up to one day on card-
board and up to three days on plastic (polypropylene) and
stainless steel[4, 7, 8]. Surfaces are easily decontaminated
with household disinfectants that kill the virus outside the
human body or on the hands[4]. Disinfectants or bleach
are not a treatment for COVID - 19 and cause health prob-
lems when used improperly, such as when used inside
the human body[8]. Numerous researches claim that the
various symptoms of this disease have so far not been
fully understood[7, 8].
Coronavirus is easily spread between people - faster
than the flu, but less than measles[4]. Estimates of the
number of people infected with someone with COVID-19
(R0) have varied considerably. WHO’s initial estimates
of R0 were 1.4-2.5 (mean 1.95), but a more recent review
found that baseline R0 (without controls) was higher than
3, 28 and the median R0 at 2.79.
2.4 Symptoms
Fever is known as the most common symptom. How-
ever, some people who have other health problems and
older people suffer from fever later in the disease[10, 11].
A lack of fever does not verify that a person is not a
carrier of the disease. Other symptoms developed by car-
riers of this virus are coughing, loss of appetite, fatigue,
shortness of breath, sputum production and muscle and
joint pain[12]. Symptoms such as vomiting, nausea, and
diarrhea were seen in patients to different degrees[13, 14].
Less common symptoms include runny nose, sneezing,
sore throat and skin lesions, among others[15]. Other cases
seen in several countries initially presented with palpi-
tation and chest tightness[16]. In addition, a decrease in
smell or taste disturbances may occur[17]. As with most
infections, the average incubation period for COVID -
19 (when a person first is infected and when they de-
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velop symptoms) is five to six days, but it usually varies
from one to 14 days, around 10% of cases exceeding this
period[18, 19]. It is noted that a minority of cases does
not develop any perceptible symptom at a given time[20].
These asymptomatic carriers tend not to be tested, and
their role in transmission is not yet fully understood[21].
However, preliminary evidence suggests that they may
be contributing to the spread of the disease[22]. Figure 4
shows some symptoms of coronavirus.
Figure 4. Symptoms of Coronavirus disease 2019
2.5 Review
Scopus website, 162 documents have been published
since January 2020 up to now analysing coronavirus,
which constituted of 82 articles, 34 letters, 18 editorials,
16 reviews, and 10 notes. All those articles were pub-
lished in various subject areas such as medicine (135doc-
uments); immunology and microbiology (16 documents);
Biochemistry, Genetics and Molecular Biology (15 doc-
uments); Pharmacology, Toxicology and Pharmaceutics
(8); and Psychology (8).
Huang et al.[23] carried out clinical, epidemiological,
radiological, biological studies, as well as the treatment
of a group of coronavirus patients in Wuhan, China. All
the data collected were obtained using the WHO stan-
dardized data collection. Patients and their families were
examined to verify epidemiological data and symptoms.
An analysis and comparison were made between the re-
sults of examinations of patients admitted to intensive
care and those who were not; 41 patients were identi-
fied as laboratory-confirmed Corunavirus infected and
hospitalized on January 2. These patients consisted of
73% men; the 32% of these patients suffered from an
underlying disease, such as hypertension (15%), diabetes
(20%), and cardiovascular disease (6%). Of these patients,
66% were exposed to the Huanan seafood market. As
common symptoms, it was noticed in the patients that
98% had a fever, 76% had a cough, and the 44% showed
signs of fatigue. Furthermore, it was noted that 8% of
patients had a production of headache; haemoptysis (5%);
sputum production (28%); dyspnoea (55%). It was inter-
esting to note that all of these patients had pneumonia
with abnormal chest CT results. The 29% of patients had
complications manifested by acute respiratory distress,
15% by RN Aaemia, and 12% with acute cardiac injury.
In total, 15% died.
In April 2020, research carried out, by Peter Byass[24],
in the purpose of studying the spread of COVID-19 in
China, resulting from the link between identified cases
and ecological factors, such as temperature, population
density, precipitation, and solar radiation. The analysis
was based on 18,069 patients identified between January
and February. Among the 15,539 cells in the grid, only
559 (3.6%) had at least one case, and these were used in
the construction of a Poisson regression model. The find-
ing of this research showed that meteorological conditions
can have a significant effect under the propagation and
understanding of COVID-19. Fei Zhou et al.[25] studied
the clinical course of COVID-19 disease, viral excretion,
as well as the risk factors for mortality. This research
was based on all hospitalized patients over 18 years of
age with COVID-19, identified at Jinyintan and Wuhan
hospitals in China, who were released and died on Jan-
uary 31, 2020. The clinical, laboratory, demographic,
treatment, and sampling data for the detection of viral
RNA were provided by the medical records patients. The
risk factors associated with hospital deaths were assessed
using logistic regression methods. This study evaluated
the cases of 191 patients, with 137 cures and 54 who
died in the hospital. Examinations showed that 48% of
these patients showed signs of comorbidity; such as hy-
pertension (30%), diabetes (19%). A large increase in
in-hospital deaths of patients with advanced age was ob-
served. Findings showed that potential risk factors for
advanced age with a high Sequential Organ Failure As-
sessment score and a d-dimer greater than 1 µg/mL may
help clinicians detect patients with poor prognosis at an
early stage. According to Torres and Siche[26], COVID
19 is wreaking havoc, in fact, in the short and medium
term, rich and poor, professional and non-professional,
regardless of race, religion, sex or age, will undoubtedly
suffer from a mental disorder associated with COVID-19.
Governments will not only face economic problems, but
may also face a bigger problem, the mental health of their
people. In Addition, Lascaux et al.[27] had made a sta-
tistical analysis of the evolution of COVID-19 infection
in Puglia, Sardinia, Sicily which are cities distributed in
three Italian regions, with a look under different beta-
thalassemic prevalences, in the aim to verify the existing
link. The findings explained that the prevalence of the
beta thalassemic heterozygous population is correlated
with immunity to COVID-19, by regression.
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Nowadays, there is no effective vaccine to combat
this coronavirus pandemic. Indeed, countermeasures are
based on preventing or slowing down person-to-person
transmission[28]. More specifically, increasing efforts are
being made to prevent or reduce transmission to front-line
health workers. However, one of the major concerns of
the international community is the problem of a shortage
in the supply chain of personal disposable and critical pro-
tective equipment[28]. The studies of Liu et al.[29] aims
to explore associations between the number of new cases
of coronavirus 2019 and weather factors in 30 provincial
capitals of China. The data compiled took into account
the number of confirmed people, the ambient temperature,
the daytime temperature range, the absolute humidity and
the migration scale index for each city studied between
January 20 and March 2, 2020. All First, a non-linear re-
gression was used to analyse the link between the number
of cases confirmed by COVID-19 and the meteorological
factors. Linear models with a negative binomial distri-
bution were fitted to assess the direct effect of weather
factors on the number of confirmed cases. Subsequently,
a meta-analysis was conducted to quantify the grouped
effects. The results showed that Each 1◦C increase in
room temperature and daytime temperature range was
linked to the decrease in the number of daily confirmed
cases of COVID19. Furthermore, it was found that the
patient’s vulnerability period was cumulative up to 14
days. According to Vecchio et al.[30], Overall, the Covid-
19 pandemic has caused considerable damage to major
challenges in all countries of the world. The death rate
is very high in people with a history of opioid use disor-
der and addiction. In most countries, a reorganization of
the health system has been envisaged to combat the pan-
demic. The measures recommended to limit the spread of
COVID19, such as isolation and social isolation, reduce
the mortality percentage and the burden on health and so-
cial protection systems. The studies of Merindol et al.[31]
showed that rapid and reliable screening for SARS-CoV-2
is necessary to estimate the viral spread and reduce the
pandemic we are facing. The direct rRT-PCR method,
without RNA extraction using SeeGene AllplexTM 2019-
nCoV rRT-PCR was analysed. In addition, the effect of
the composition of swab storage media on the efficiency
of PCR was evaluated. The results showed that the See-
Gene and Altona tests had similar efficacy. The study con-
ducted by Moghanibashi[32] aimed to analyse the anxiety
rate of the Iranian population during the period of spread
of the COVID-19 epidemic. A total of 10,754 participants
living in 31 Iranian provinces responded to the question-
naires on March 1 and March 9, 2020, on social networks.
The results showed that the level of anxiety was highest
among women and the group of ages 21 to 40. Further-
more, the level of anxiety was significant in people who
had at least one family member with COVID-19. Michael
Peters et al.[33] studied genes for ACE2 and TMPRSS2,
and of the intercellular adhesion molecule 1 (rhinovirus
receptor as a comparator), which originates from differ-
ent sputum cells from 330 participants in the research
program on asthma. The results showed a high level of
ACE2 and TMPRSS2 in men. Diabetes patients and the
African-American population justified the monitoring of
these asthma subgroups for poor results COVID19. The
lowest concentration of ACE2 and TMPRSS2 with the
use of ICS qualifies a prospective study of the use of ICS
as a predictor of reduced susceptibility to SARS-CoV-2
infection and morbidity from COVID19 reduced. The
objective of the research conducted by Wei-cai Dai et
al.[34] were compared data from images of pulmonary
CT scan of certain patients with COVID-19 in China,
and other known lung diseases. The results showed that,
unlike NAAT of SARS-CoV-2, which limit detections
and often show false negative results, chest CT quickly
detects lung lesions and diagnoses imaging at the start.
Other important studies related COVID19 were detailed
in the literature[35–40].
3 Coronavirus cases in the world
Figure 5 shows the evolution of coronavirus since De-
cember 2019 up to June 2020. The global confirmed cases
showed are 6271,577 (Figure 5a); the global death cases
are 375,683 and global recovered cases are 2697,873.
These results show the death rate has reached the 5.99%
this day in the world. Figure 6 gives in details the number
of cases of COVID-19 evaluated by the Center for Sys-
tems Science and Engineering (CSSE) at Johns Hopkins
University (JHU).
Figure 7 shows recent data published by European Cen-
tre for Disease Prevention and Control (ECDC).
The rate of people infected is increasing in some coun-
tries in Africa. For example, on June 09, 2020, 196 570
cases in all the Africa’s countries; the five countries re-
porting most cases are South Africa (50 879), Egypt (35
444), Nigeria (12 801), Algeria (10 265) and Ghana (9
910). Number of people deaths in this continent 5 346;
the five countries reporting most deaths are Egypt (1 271),
South Africa (1 080), Algeria (715), Sudan (372) and
Nigeria (361).
Europe: 2 084 509 cases; the five countries reporting
most cases are Russia (476 658), United Kingdom (287
399), Spain (241 717), Italy (235 278) and Germany (184
543).Europe: 179 385 deaths; the five countries reporting
most deaths are United Kingdom (40 597), Italy (33 964),
France (29 209), Spain (27 136) and Belgium (9 609).
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Figure 5a. Cumulative confirmed cases up to 06/02/2020 in the world of
COVID-19 given by Centre for Systems Science and Engineering (CSSE) at
Johns Hopkins University (JHU)
Figure 5b. Active cases on 06/02/2020 in the world of COVID-19 given by
Center for Systems Science and Engineering (CSSE) at Johns Hopkins
University (JHU)
Figure 5c. Incidence rate on 06/02/2020 in the world of COVID-19 given by
Center for Systems Science and Engineering (CSSE) at Johns Hopkins
University (JHU)
Figure 5d. Case fatality ratio on 06/02/2020 in the world of COVID-19 given
by Center for Systems Science and Engineering (CSSE) at Johns Hopkins
University (JHU)
Figure 5. The evolution of coronavirus since December 2019
up to June 2020
Figure 6. Global confirmed cases from December 2019 to June
2020
America: 3 403 398 cases; the five countries reporting
most cases are United States (1 961 185), Brazil (691
758), Peru (199 696), Chile (138 846) and Mexico (120
102).America: 185 311 deaths; the five countries report-
ing most deaths are United States (111 007), Brazil (36
455), Mexico (14 053), Canada (7 835) and Peru (5 571).
Asia: 1 375 372 cases; the five countries reporting most
cases are India (266 598), Iran (173 832), Turkey (171
121), Pakistan (108 317) and Saudi Arabia (105 283).
Asia: 35 407 deaths; the five countries reporting most
deaths are Iran (8 351), India (7 466), Turkey (4 711),
China (4 638) and Pakistan (2 172).
Oceania: 8 733 cases; the five countries reporting most
cases are Australia (7 265), New Zealand (1 154), Guam
(180), French Polynesia (60) and Northern Mariana Is-
lands (28). Oceania: 131 deaths; the four countries report-
ing deaths are Australia (102), New Zealand (22), Guam
(5) and Northern Mariana Islands (2).
Seen that the limited testing and challenges in the at-
tribution of the cause of death means that the number of
confirmed deaths may not be an accurate count of the true
number of deaths from COVID-19. The 10 countries the
most affected by this pandemic are: United States, United




Each new day brings thousands of more Covid-19
deaths around the world. Indeed, according to a last
count established by the Center for Systems Science and
Engineering (CSSE) at Johns Hopkins University (JHU),
in the 188 countries listed, for a total confirmed case
estimated around 6273402, the 6% died. These figures
underestimate the real scale of the global health crisis be-
cause many deaths outside hospitals are neither tested nor
counted, for example, in the United States, where the rules
vary from one jurisdiction to another. Containment mea-
sures, which affect 4 billion people worldwide, raise fears
of a global recession[41]. Unemployment has increased
considerably since the start of the crisis (more than 22
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Figure 7. Total confirmed COVID-19 deaths
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million in the USA). Food banks are overwhelmed around
world... The human cost of confinement is vey high. In
addition, that should translate into higher mortality, even
after the pandemic is over.
4.2 Economic consequences
According to the Managing Director of the IMF, the
coronavirus pandemic will cause ”the worst economic
consequences since the Great Depression” of 1929. In-
deed, more than 170 countries will experience a contrac-
tion in their per capita income[42].
According to the International Labor Organization
(ILO)[43], 1.6 billion people worldwide, will be affected
by this pandemic. In the first month of the crisis alone, the
income of informal workers fell by 60% worldwide. This
translates into a fall of 81% in Africa and the Americas,
21.6% in Asia-Pacific and 70% in Europe and Central
Asia. Without alternative sources of income, these work-
ers and their families will no longer have a livelihood.
Hours of work worldwide decreased in the first quarter
by approximately 4.5% (equivalent to approximately 130
million full-time jobs, based on a 48-hour workweek)
from the fourth quarter 2019. In the second quarter, the
situation should worsen further due to the extension of
the containment measures.
4.3 Environmental consequences
During the initial assessment of the 2008 global finan-
cial crisis, overall CO2 emissions from the combustion of
fossil fuels and the production of cement had decreased
by 1.4%, which did not prevent them from increasing by
5 , 9% in 2010.
Today, according to the Center for Research on En-
ergy and Clean Air, methods used to contain the spread
of the coronavirus, such as quarantines and travel bans,
have resulted in a 25% reduction in carbon emissions in
China[44, 45]. In the first month of containment, China
produced about 200 million metric tons of carbon dioxide
less than over the same period in 2019[45]. Delhi in India
has experienced the most drastic change with a 60% drop
in air pollution.
5 Comparison
In this section, we compare the effect of COVID-19
and other diseases. In this sense, Figure 8 shows the case
fatality rate by age of COVID 19. The fatality rate is 2.3%
for all the ages; of 0.2% between 10 and 39 years old;
of 8% between 70-79; and 14.8% for the people over 80
years old.
On this figure, it was seen that the degree of vulnerabil-
ity increases with age. The age group over 80 is the most
Figure 8. Case fatality rate by age according to Doc James[46]
vulnerable. Between 10 and 49, the mortality rate is from
0.2% to 0.4%. It is interesting to notice that between 60
and 79 years, the mortality concentration is estimated to
be between 3.6 and 8%. (Figure 9)
Among all the diseases studied in this research, it is
seen that the mortality rate is 100% in the case of pneu-
monia plagues and rabies. One patient of Covid19 can
infect in average 3 people, while one patient of Malaria
will be infected 17 healthy people.
6 Treatment
The COVID-19 pandemic is new and unexpected. This
can be destabilizing and cause a feeling of loss of control.
It is normal for individuals and communities to experi-
ence sadness, stress, confusion, fear and worry during a
crisis. Overall, coronavirus infections are diagnosed by
health care providers based on the symptoms presented
and are confirmed by laboratory tests. The majority of
people with mild symptoms will recover on their own.
However, if you are concerned about your symptoms, you
should closely monitor them and contact your health care
provider. At this time, there is no vaccine or treatment
yet to cure or prevent this disease. However, research
and development activities are underway. The COVID-19
pandemic has prompted a global review of treatments
that could be used to treat or prevent disease. The flu
shot does not protect you from coronaviruses, but it does
protect you from the flu.
For benign forms of Covid-19, treatment is symp-
tomatic, it is recommended:
(1) Take paracetamol for fever and body aches,
(2) To rest, drink lots of water to rehydrate;
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Figure 9. Comparison between Coronavirus and other diseases[41]
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(3) Unclog the nose with physiological saline. Contain
yourself and respect hygiene measures to avoid contami-
nating those around you.
7 Protection
Prevention against coronavirus is the same as for in-
fluenza and gastroenteritis. It is thus advised:
(1) Wash hands regularly with soap and water, rubbing
well between your fingers for at least twenty seconds and
rinsing thoroughly;
(2) Favour telework when possible.
(3) Avoid all unnecessary trips and gatherings;
(4) Any trip abroad should be postponed as far as pos-
sible.
(5) In places with a high concentration of the popu-
lation, fix a distance (social distance) of at least 1.5m
between two people.
(6) Cough or sneeze into your elbow or a disposable
handkerchief, to throw in a trashcan.
(7) Avoid kissing or shaking hands to say hello.
Temporary measures such as the closure of nurseries,
schools, colleges, high schools and universities are taken
to limit the spread of SARS-CoV-2. Schools and airports
are reopening is gradually observed in each country ac-
cording to the reduction in the number of people infected
with this disease.
8 Questions with questionable answers (Qi)
(Q1): Why in the United States, blacks and the
poor people are most affected by Covid-19?
The Washington Post reports that in the state of Michi-
gan, 40% of deaths from Covid-19 come from the black
community, while it represents only 14% of the popula-
tion. The high number of deaths in the black community
in the United States is largely due to centuries of segre-
gation and discrimination that have relegated a very high
proportion of blacks to poor and overcrowded neighbor-
hoods where access to health services is largely insuffi-
cient. African-Americans are particularly vulnerable to
the coronavirus epidemic because they are more likely to
be in low-paid jobs, which cannot be done by telework,
and do not offer health insurance or sickness benefits[46].
Several studies show that the poor and marginalized
are more prone to respiratory and cardiovascular diseases,
cancers, and strokes[47]. They are therefore also the most
affected by the coronavirus epidemic. In the United States,
poverty and ethnicity often go hand in hand[47]. Some
studied carried out in 2018, showed that 11% of whites
live in households with incomes below the official poverty
line, compared to 23% of African Americans and 19%
of Hispanics. People of color are more likely to live in
poor neighborhoods where access to basic necessities and
medical care is restricted[48].
Long-time, it has been proven that there is a causal link
between poverty and the spread of infectious diseases.
In poor neighborhoods, the number of hospitalizations
related to influenza is almost double that observed in
affluent neighborhoods. This is also the case for paediatric
hospitalizations due to secondary bacterial pneumonia.
The same goes for tuberculosis, which is very common in
poor neighborhoods. These trends are not all explained
by the fact that these areas are more populated.
Tuberculosis is particularly linked to the socioeco-
nomic status of individuals[49]. Already in the early twen-
tieth century, when the United States was faced with a
generalized epidemic of tuberculosis, African-Americans,
immigrants and residents of disadvantaged neighborhoods
were the most affected because they did not have access
to medical care[49].
(Q2): Why does the mortality rate differ from coun-
try to country?
Perhaps, because of the health choice or different cal-
culation methods by country.
(Q3): Why, until now, Africa and China seem to be
the least infected with this pandemic?
The mortality rate is underestimated compared to the
number of people affected in some African countries and
in China.
In China, some people believe that reports on the num-
ber of people who have died from this disease have been
reduced. Others claim that in China everything is being
done not to show reality. The Communist Party especially
does not want the discontented Chinese to speak out, and
does everything to silence them[50].
(Q4): Why is the death rate low in Germany, com-
pared to other European countries such as; France,
Belgium, Italy, and England?
Because, Germany did a lot of testing very early; mor-
tality in other countries is overstated; moreover, Germany
has more places in intensive care.
(Q5): Is the coronavirus more dangerous than the
flu, SARS or Ebola?
Coronavirus has a lower mortality rate than SARS
(9.6%); it has a lower mortality rate than Ebola (50%);
nevertheless, it is a little more contagious than the flu.
(Q6) Are people with blood type O better immu-
nized against coronavirus?
About twenty scientists from several Chinese universi-
ties, hospitals or institutes have published the results of
their work, the aim of which was to make a link between
a person’s blood group and their ability to resist against a
risk of infection with Covid- 19[51].
In this study, Chinese researchers affiliated with the
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University of Shenzhen, indicate that they studied 2,100
people infected with the virus (coming from three hospi-
tals in Wuhan and Shenzhen). Among the cases observed,
10% had died. They were then compared to nearly 3,700
Wuhan residents who were uninfected[51]. They then com-
pared the proportion of people in each blood group (A,
B, AB and O) among samples of the population and pa-
tients with Covid-19. Among the 3694 ”lambda” people
on whom the study was based, the researchers noted a
distribution of approximately 32% of blood group A; 25%
of B; 9% of AB and 34% of O. Among the 1775 patients
tested positive for Covid-19 at Wuhan Jinyintan hospital,
this distribution was 38% of blood group A, 26% of B,
10% of AB and 26% of O. under base of these analysis,
they have conclude that there are 33 % less risk of being
contaminated by coronavirus if you are of blood group
O[51].
(Q7): When will Coronavirus end?
According to a study conducted by Princeton Univer-
sity and published in the journal Science, SARS-CoV-2
will not be neutralized by summer warming. In a univer-
sity statement, Rachel Baker, co-author of the study, said,
”We anticipate that warmer, wetter climates will not slow
the virus in the initial stages of the pandemic.” According
to the researcher, the virus ”will spread quickly, whatever
the weather.” It is specified that in the absence of a vac-
cine or of control measures, the coronavirus will therefore
gradually contaminate a larger part of the population. It
is only after leaving the pandemic phase that Coivd-19
could become seasonal.
(Q8): How long is an infected person contagious?
In early March, the very serious American scientific
journal “Lancet” (https://www.thelancet.com/coronaviru
s), published a study on the contagiousness of Covid-
19, establishing that it had a very high and very long
contagiousness. This work was carried out by Chinese
doctors who followed for several weeks, in December
and January, 191 Covid-19 patients in two hospitals in
Wuhan, China. They found that after clinical recovery,
almost a third of the patients continued to excrete the
virus. Doctors have found in the patients seen that the
duration of viral shedding varies from 8 to 37 days after
the onset of the first symptoms.
(Q9): Is it possible to contract Covid-19 twice?
People infected with this virus develop antibodies that
allow them to avoid further infection. But the duration
of this immunity can be more or less long. Meanwhile,
reports of clinically recovered Covid-19 patients develop-
ing symptoms of the disease have been reported in Japan
and China. Indeed, the special cases of infected patients,
clinically cured and who develop symptoms again, should
be screened again. But a priori, they do not develop it a
second time: it may be due to another classic seasonal
virus, or it may be a consequence of a severe form of
coronavirus, which can subsequently cause pulmonary
super infection.
9 Conclusion
All studies making projections on the future are un-
certain because no one can accurately predict the future
(example: no one to predict the disease of Coronavirus,
Ebola, SARS, Spanish flu, etc.). However, we can base
ourselves on certain current phenomena to predict the
near or far future with degrees of uncertainty not very
high as asserted by certain authors. Therefore, under ba-
sic of all these results, we can conclude that, although,
Coronavirus either an invisible enemy, it constitutes the
majority of the case a warning for humanity. Until now,
there are had several pandemics and epidemics in the past
(Black plague, 250M of deaths; Smallpox, 300M, etc.). It
is likely to have the same situation in the future, except if
humans change totally of behaviour.
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